C

CareDx
D

CDNA

16.960
USD
-0.19
(-1.11%)
مغلق
حجم التداول
32,709
الربح لكل سهم
-0
العائد الربحي
-
P/E
15
حجم السوق
944,342,111
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
HOLX
HOLX
-0.220
(-0.40%)
54.260 USD
IDXX
IDXX
-3.60
(-0.71%)
501.44 USD
ILMN
ILMN
-0.160
(-0.20%)
80.380 USD
PODD
PODD
0.41
(0.13%)
321.44 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
المزيد
الأخبار المقالات

العنوان: CareDx

القطاع: Healthcare
الصناعة: Diagnostics & Research
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.